|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Percutaneous closure of secundum type atrial septal defects:More than 5-year follow-up显示文摘AIM: To investigate long-term efficacy of two different devices more than five years after percutaneous atrial septal defect(ASD) closure in adults.METHODS: All patients who underwent percutaneous closure of an ASD in the St. Antonius Hospital, Nieuwegein, The Netherlands, between February 1998 and December 2006 were included. Percutaneous closure took place under general anaesthesia and transesophageal echocardiographic moni toring. Transthoracic echocardiography(TTE) was performed 24 h post-procedure to visualize the device position and to look for residual shunting using color Doppler. All complications were registered. All patients were invited for an outpatient visit and contrast TTE more than 5-years after closure. Efficacy was based on the presence of a residual right-to-left shunt(RLS), graded as minimal, moderate or severe. The presence of a residual left-to-right shunt(LRS) was diagnosed using color Doppler, and was not graded. Descriptive statistics were used for patients' characteristics. Univariate analysis was used to identify predictors for residual shunting.RESULTS: In total, 104 patients(mean age 45.5 ± 17.1 years) underwent percutaneous ASD closure using an Amplatzer device(ASO) in 76 patients and a Cardioseal/Starflex device(CS/SF) in 28 patients. The mean follow-up was 6.4 ± 3.4 years. Device migration occurred in 4 patients of whom two cases occurred during the index hospitalization(1 ASO, 1 CS/SF). The other 2 cases of device migration occurred during the first 6 mo of follow-up(2 CS/SF). The recurrent thrombo-embolic event rate was similar in both groups: 0.4% per follow-up year. More than 12 mo post-ASD closure and latest follow-up, new-onset supraventricular tachyarrhythmia's occurred in 3.9% and 0% for the ASO and CS/SF group, respectively. The RLS rate at latest follow-up was 17.4%(minimal 10.9%, moderate 2.2%, severe 4.3%) and 45.5%(minimal 27.3%, moderate 18.2%, severe 0%) for the ASO- and CS/SF groups, respectively. There was no residual LRS in both groups.CONCLUSION: Percutaneous ASD closure has good long-term safety and efficacy profiles. The residual RLS rate seems to be high more than 5 years after closure, especially in the CS/SF. Residual LRS was not observed. | Roel JR Snijder Maarten J Suttorp Jurrien M Ten Berg Martijn C Post | 2015 | World Journal of Cardiology2015，7，3： | 6 |
| 2 | Clinical-grade ex vivo?expanded human natural killer cells up-regulate activating recep?tors and death receptor ligands and have enhanced cytolytic activity against tumor cells 显示文摘 | Berg M Lundqvist A Jr Mccoy P | 2009 | Cytotherapy2009，11，3： | 1 |
| 3 | Endothelin-stimulated glucose uptake:effects of intracellular Ca2+,cAMP and glucosamine显示文摘 | Wu-Wong JR Berg CE Dayton BD | | 0，，： | 1 |
| 4 | High-density lipoprotein cholesterol and prognosis after myocardial infarction 显示文摘 | Berge KG Canner PL Hainline A Jr | 1982 | Circulation1982，66，： | 1 |
| 5 | Requirements for ICAM-1 immunogene therapy of lymphoma 显示文摘 | Kanwar JR Berg RW Yang Y | 2003 | Cancer Gene Ther2003，10，6： | 1 |
| 6 | Are epilepsy clas- sifications based on epileptic syndromes and seizure types outdated显示文摘 | Engel J Jr Berg A Andermann F et ai | 2006 | Epileptic Discord2006，8，2： | 1 |
| 7 | Effect of positive pressure on venous return in volume - loaded cardiac surgical patients 显示文摘 | Van den Berg PC Jansen JR Pinsky MR | 2002 | J Appl Physiol2002，92，3： | 1 |
| 8 | Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes 显示文摘 | Larsen JR Sjoholm H Berg TJ | 2004 | Diabetes Care2004，27，： | 1 |
| 9 | Calcineurin Inhibitors in the Treatment of Adult Autoimmune Hepatitis:A Systematic Review显示文摘Background and Aims:A considerable number of au-toimmune hepatitis(AIH)patients completely or partially fail on first-line treatment.Several studies on the use of calcineurin inhibitors(CNIs)in the treatment of AIH have been published without focusing on indication.The aim was to assess the efficacy of CNIs in the treatment of adult AIH patients,specifically focusing on indication:first-line intolerant and with first-line insufficient response(failure to achieve or maintain remission),and with second versus third-line treatment.Methods:A literature search included studies on the use of CNIs in adult AIH.Patients with past or present use of CNIs from the Dutch AIH group cohort were added.The primary endpoint was biochemical remission while using CNIs.Secondary endpoints were biochemical response,treatment failure,and adverse effects.Results:Twenty studies from the literature and nine Dutch patients were included describing the use of cyclosporine in 59 and tacrolimus in 219 adult AIH patients.The CNI remission rate was 53%in patients with insufficient response to first-line treatment and 67%in patients intolerant to first-line treat-ment.CNIs were used as second-line treatment in 73%with a remission rate of 52%and as third-line treatment in 22%with a remission rate of 26%.Cyclosporine was discontin-ued in 13%and tacrolimus in 11%of patients because of adverse events.Conclusions:CNIs as rescue treatment in adult AIH patients are reasonably effective and safe both with insufficient response or intolerance to previous treat-ment.Prospective studies are needed. | Martine AMC Baven-Pronk Joffre M.Hew,Jr Maaike Biewenga Maarten E.Tushuizen Aad P.van den Berg Gerd Bouma Johannes T.Brouwer Bart van Hoek 无 | 2022 | Journal of Clinical and Translational Hepatology2022，10，6： | 1 |
| 10 | The acute coronary syndrome diagnosis and prognostic evaluation by troponin I is influenced by the test system affinity to different troponin complexes显示文摘 | Heller G Jr Berg K | 2000 | Clin Chem Acta2000，293，12： | 1 |
| 11 | Forced-Convection Heat Transfer to Nitrogen in the Vicinity of the Critical Point显示文摘 | Von Berg R L Williamson K D Jr Edeskuty F J | 1970 | Advances in Cryogenics Engineering1970，15，： | 1 |
| 12 | Effect of positive pressure on venous return in volume-loaded cardiac surgical patients显示文摘 | van den Berg PC Jansen JR Pinsky MR | 2002 | J Appl Physiol2002，92，3： | 1 |
| 13 | The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroen- docrlne tumors (nets) : well-differentiated nets of the distal colon and rectum 显示文摘 | Anthony LB Stm- berg JR Klimstra DS | 2010 | Pancreas2010，39，6： | 1 |
| 14 | The acute coronary syndrome diagnosis and prognositic evaluation by troponin I is influenced by the test system affinity to different troponin complexes显示文摘 | Heller G Jr Berg K | 2000 | Clin Chem Acta2000，293，12： | 1 |
| 15 | Crystal structure of the long- chain fatty acid transporter FadL 显示文摘 | Berg BVD Black PN Clemons Jr WM | 2004 | Science2004，304，： | 1 |
| 16 | 查看详情显示文摘 | Berna F Behar A Shahack-Gross R Berg J Boaretto E Gilboa A Sharon I Shalev S Shilshtein S Yahalom-Mack N Zorn JR & Weiner S | | 0，，： | 1 |
| 17 | Leukemia incidence after iodine exposure显示文摘 | Hall P Boice JD Jr Berg G | 1992 | Lancet1992，304，： | 1 |
| 18 | Population genetics of the common squid Loligo pealei Lesueur 显示文摘 | Garthwaite R L Berg Jr C J Harrigan J | 1989 | Biol Bull1989，177，： | 1 |
| 19 | Ovarian cancer biomarkerperformace' in prostate, lung colorectal and ovarian cancerscreening trial specimens 显示文摘 | CramerDW Bast Jr RC Berg CD | 2011 | Cancer Prev Res (Phila)2011，4，3： | 1 |
| 20 | Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens 显示文摘 | Cramer DW Bast RC Jr Berg CD | 2011 | Cancer Prev Res (Phila)2011，4，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员